This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Claudio, L. Articles by Brosnan, C. F. Search for Related Content PubMed PubMed Citation Articles by Claudio, L. Articles by Brosnan, C. F.

American Journal of Pathology, Vol 135, 1157-1168, Copyright © 1989 by American Society for Investigative Pathology

REGULAR ARTICLES

Increased vesicular transport and decreased mitochondrial content in blood-brain barrier endothelial cells during experimental autoimmune encephalomyelitis

L Claudio, Y Kress, WT Norton and CF Brosnan
Department of Pathology, Albert Einstein College of Medicine, Bronx, New York.

Mechanisms involved in the loss of blood-brain barrier function in Lewis rats with experimental autoimmune encephalomyelitis (EAE) were examined using horseradish peroxidase (HRP) as a tracer. In animals injected with HRP before fixation, tracer was observed in two intracytoplasmic compartments: multivesicular bodies (presumably secondary lysosomes) and transcytotic vesicles. Quantitative morphometry of electron micrographs of capillary endothelial cells demonstrated a 5.2-fold increase in these vesicles. This increase in vesicular transport was associated with a decrease in mitochondrial content from 13.7% of the endothelial cytoplasmic area in the normal rat to 4.2% in EAE rats at the height of clinical disease. These alterations correlated with the clinical course of EAE. In animals infused with tracer after fixation, tracer was restricted to areas of cellular inflammation. Immunogold staining of endogenous albumin demonstrated the presence of albumin in cytoplasmic vesicles and in channel-like tubular structures adjacent to endothelial cell junctions. These results indicate that there is a role for vesicles in transendothelial cell transport and edema formation in animals with EAE.

This article has been cited by other articles:

				A. T. Argaw, Y. Zhang, B. J. Snyder, M.-L. Zhao, N. Kopp, S. C. Lee, C. S. Raine, C. F. Brosnan, and G. R. John IL-1beta Regulates Blood-Brain Barrier Permeability via Reactivation of the Hypoxia-Angiogenesis Program J. Immunol., October 15, 2006; 177(8): 5574 - 5584. [Abstract] [Full Text] [PDF]

				L. L. Pearce, A. J. Kanai, L. A. Birder, B. R. Pitt, and J. Peterson The Catabolic Fate of Nitric Oxide. THE NITRIC OXIDE OXIDASE AND PEROXYNITRITE REDUCTASE ACTIVITIES OF CYTOCHROME OXIDASE J. Biol. Chem., April 12, 2002; 277(16): 13556 - 13562. [Abstract] [Full Text] [PDF]

				J. Guy, X. Qi, H. Wang, and W. W. Hauswirth Adenoviral Gene Therapy With Catalase Suppresses Experimental Optic Neuritis Arch Ophthalmol, November 1, 1999; 117(11): 1533 - 1539. [Abstract] [Full Text] [PDF]

				K. W. Westland, J. D. Pollard, S. Sander, J. G. Bonner, C. Linington, and J. G. McLeod Activated non-neural specific T cells open the blood–brain barrier to circulating antibodies Brain, July 1, 1999; 122(7): 1283 - 1291. [Abstract] [Full Text] [PDF]

				J. Guy, X. Qi, and W. W. Hauswirth Adeno-associated viral-mediated catalase expression suppresses optic neuritis in experimental allergic encephalomyelitis PNAS, November 10, 1998; 95(23): 13847 - 13852. [Abstract] [Full Text] [PDF]

				C. Bolton and C. Paul MK-801 Limits Neurovascular Dysfunction during Experimental Allergic Encephalomyelitis J. Pharmacol. Exp. Ther., July 1, 1997; 282(1): 397 - 402. [Abstract] [Full Text]

				H. E. d. Vries, J. Kuiper, A. G. d. Boer, T. J. C. V. Berkel, and D. D. Breimer The Blood-Brain Barrier in Neuroinflammatory Diseases Pharmacol. Rev., June 1, 1997; 49(2): 143 - 156. [Abstract] [Full Text] [PDF]